Hepatitis C Screening and Antibody Prevalence Among Newly Arrived Refugees to the United States, 2010–2017

Author:

Urban Kailey,Payton Colleen,Mamo Blain,Volkman Hannah,Giorgio Katherine,Kennedy Lori,Bomber Yuli Chen,Rodrigues Kristine Knuti,Young Janine,Tumaylle Carol,Matheson Jasmine,Tasslimi Azadeh,Montour Jessica,Jentes Emily

Abstract

AbstractSix refugee screening sites collaborated to estimate the prevalence of hepatitis C virus (HCV) antibodies among newly arrived refugees in the United States from 2010 to 2017, identify demographic characteristics associated with HCV antibody positivity, and estimate missed HCV antibody-positive adults among unscreened refugees. We utilized a cross-sectional study to examine HCV prevalence among refugees (N = 144,752). A predictive logistic regression model was constructed to determine the effectiveness of current screening practices at identifying cases. The prevalence of HCV antibodies among the 64,703 refugees screened was 1.6%. Refugees from Burundi (5.4%), Moldova (3.8%), Democratic Republic of Congo (3.2%), Burma (2.8%), and Ukraine (2.0%) had the highest positivity among refugee arrivals. An estimated 498 (0.7%) cases of HCV antibody positivity were missed among 67,787 unscreened adults. The domestic medical examination represents an opportunity to screen all adult refugees for HCV to ensure timely diagnosis and treatment.

Funder

National Center for Emerging and Zoonotic Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Epidemiology

Reference25 articles.

1. Polaris Observatory HCV, Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modeling study. Lancet Gastroenterol Hepatol. 2017;2(3):161–76. https://doi.org/10.1016/S2468-1253(16)30181-9.

2. Hofmeister MG, Rosenthal EM, Barker LK, et al. Estimating prevalence of Hepatitis C virus infection in the United States, 2013–2016. Hepatology. 2019;69(3):1020–31. https://doi.org/10.1002/hep.30297.

3. Hepatitis C, Questions and Answers for Health Professionals. Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm. Published August 7, 2020. Accessed January 17, 2023.

4. Admissions & Arrivals. Refugee Processing Center. https://www.wrapsnet.org/admissions-and-arrivals/. Published 2021. Accessed August 13, 2021.

5. Refugee Health Guidance. Centers for Disease Control and Prevention. https://www.cdc.gov/immigrantrefugeehealth/guidelines/refugee-guidelines.html.Published March 16, 2021.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3